Novo Nordisk Ends Cell Therapy Research Amid Major Restructuring
Novo Nordisk; cell therapy; restructuring; job cuts; diabetes; cost-cutting; R&D strategy; biotech; obesity; partnership cancellations
FDA Drug Approvals in 2025 Remain Within Recent Averages Amid Agency Upheaval
FDA; drug approvals; 2025; new molecular entities; CDER; CBER; trends; novel drugs
No Recent News Specifically About ‘Click here to continue reading’
click here to continue reading; news; recent news; web navigation; internet phrase
AstraZeneca Reaches Drug Pricing Deal with White House, Becomes Second Pharma to Do So
AstraZeneca; White House; drug pricing; Medicaid; TrumpRx; most-favored-nation pricing; tariffs; Pfizer; drug discounts
Regeneron Heads to FDA Seeking Approval for Game-Changing Hearing Loss Gene Therapy
Regeneron; hearing loss; gene therapy; DB-OTO; FDA approval; OTOF gene; CHORD trial
Ypsomed Invests $248 Million to Establish First U.S. Manufacturing Site in North Carolina
Ypsomed; manufacturing expansion; U.S. facility; Holly Springs; North Carolina; CHF 200 million; self-injection systems; job creation; global growth strategy; medical technology
Satellos Advances Duchenne Pill Trial in Children; Idorsia Raises $81 Million
Satellos; Duchenne muscular dystrophy; SAT-3247; Phase 2 clinical trial; children; FDA IND submission; oral small-molecule therapy; Idorsia; fundraising; biotech
Biopharma Deal Activity Shows Uptick in Q3 2025: Signs of Recovery and Emerging Trends
biopharma; Q3 2025; deal activity; M&A; licensing; therapeutic diversification; early-stage assets; China; US; Europe; Metsera; Verona Pharma; Merus; high-value deals
Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium
Natera; ESMO Congress; IMvigor011 trial; Presidential Symposium; Signatera; molecular residual disease; muscle-invasive bladder cancer; adjuvant Tecentriq; precision medicine; clinical oncology
Somatix Readies Market Launch of First-of-its-Kind Wearable Medication Compliance Feature
Somatix; wearable technology; medication compliance; AI-enabled; gesture detection; remote patient monitoring; SafeBeing platform; dementia; partnering with Roche; digital health